Facial diplegia with hyperreflexia-a mild Guillain-Barre Syndrome variant, to treat or not to treat?
© Sethi et al. 2007
Received: 19 November 2006
Accepted: 10 April 2007
Published: 10 April 2007
Guillain Barre Syndrome (GBS) is readily diagnosed when the presentation is that of ascending weakness and areflexia. Atypical presentations with preserved, and at times, brisk reflexes, can be a diagnostic dilemma. We describe a patient with GBS who presented with facial diplegia and hyperreflexia on examination and discuss management options.
Guillain-Barre syndrome (GBS) is usually easily identified with its typical presentation of ascending weakness and areflexia on examination. It may however present atypically with preserved, and at times, brisk reflexes, leading to diagnostic dilemma. A patient with isolated facial diplegia and hyperreflexia on examination is presented. During the entire hospitalization, the patient developed no motor weakness and remained ambulatory. Whether treatment is warranted for this and other milder variants of GBS is also discussed.
A-29-year-old right-handed Caucasian woman, who works as a model, presented to the hospital with facial weakness. She reported that a week previously she had a sore throat and was seen by her doctor who prescribed antibiotics. Four days later she developed paraesthesias in her hands and feet along with severe myalgia (day 1 of neurological manifestation). On day 3, she noted weakness in eye closure when applying eyeliner. On Day 4, she was at an audition, and was unable to smile for the camera. Later that night, she participated in a runway show. She was able to walk in high heels without difficulty. However, concerns about her face brought her to the emergency department after the show.
Motor and Sensory Nerve Conductions
Median nerve (APB) Right
Tibial nerve (AH) Right
Facial nerve ®
Orb. Oculi ®
Facial nerve (L)
Orb oculi (L)
Med nerve ®
Tibial nerve ®
Facial diplegia has a number of causes including Bell's palsy, sarcoidosis (Uveo-parotid fever or Heerfordt Syndrome), Lyme disease, Hansen's disease (leprosy), diabetes, brainstem encephalitis, brainstem stroke, herpes zoster (Ramsay Hunt and Mekelson Rosenthal Syndrome), HIV and GBS. Isolated facial diplegia with minimal to no motor limb weakness has been described as a GBS variant [1, 2]. Usually in these cases areflexia helps in distinguishing GBS as the underlying etiology. Hyperreflexia as a variant in GBS has also been described and is currently not thought to be inconsistent with the diagnosis. It is thought to be due to increased motor neuron excitability and spinal inhibitory interneuron dysfunction as evidenced by increased soleus H/M ratios and abnormal appearance of H reflexes in the small muscles of the hands and feet in some patients [3, 4, 6]. Hyperreflexia in GBS patients has been associated with a milder degree of peak disability, as is seen in this patient .
Our patient presented with isolated facial diplegia. The fact that she was able to catwalk down a runaway in high heels clearly argued against any lower limb weakness at presentation. It is unclear however if GBS patients with isolated facial diplegia warrant treatment or not. The unpredictability of the early clinical course of GBS makes it difficult to judge which patient shall worsen as the disease runs its course. Treating all these "mild" cases may risk exposing patients to the potential side effects of IVIG and plasmapheresis. There is also anecdotal evidence that transient improvement in power or paraesthesias followed by worsening may occur in relation to immune treatment i.e. immune treatment itself may predispose a patient to relapse [4, 5]. In our case the treating physician who first saw her at presentation to the hospital elected to use IVIG. By the time treatment was initiated and we were involved in her care the neurological syndrome had already started to resolve as evidenced by the disappearance of paraesthesias, hence it can be debated if the patient's clinical outcome would have been any different had treatment been withheld. In their article Green et.al mention that treatment may be unnecessary in patients who remain ambulatory during the second week of illness . Observation until the eight day though is advisable to be certain that the disease does not progress or relapse.
It is not our intention by highlighting this case to discuss the physiology behind brisk reflexes in GBS but rather to raise the argument for withholding immunotherapy in isolated facial diplegia variant of GBS until the eighth day or so before committing these "mild" GBS patients, who are still able to walk, to IVIG or plasmapheresis.
- Tan EK, Lim SH, Wong MC: Facial diplegia: cranial variant of Guillain Barre syndrome. J R Soc Med 1999, 92:26–27.PubMedGoogle Scholar
- Ropper AH: Unusual clinical variants and signs in Guillain Barre syndrome. Arch Neurol 1986, 43:1150–2.PubMedGoogle Scholar
- Susuki K, Atsumi M, Koga M, Hirata K, Yuki N: Acute facial diplegia and hyperreflexia. A Guillain Barre syndrome variant. Neurology 2004, 62:825–7.PubMedGoogle Scholar
- Kuwabara S, Ogawara K, Koga M, Mori M, Hattori T, Yuki N: Hyperreflexia in Guillain Barre syndrome: relation with acute motor axonal neuropathy and anti-GM1 antibody. J Neurol Neurosurg Psychiatry 1999, 67:180–184.View ArticlePubMedGoogle Scholar
- Green DM, Ropper AH: Mild Guillain Barre syndrome. Arch Neurol 2001, 58:1098–1101.View ArticlePubMedGoogle Scholar
- Podnar S, Vodusek DB: Hyperreflexia in a patient with motor axonal Guillain-Barre syndrome. Eur J Neurol 2000, 7:727–30.View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.